Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies. It has a manufacturing facility spread over 30,000 square feet (sq. ft.) area with a large batch-sized capacity for general: tablets, capsules, oral liquids, eye drops, ointments, lotions, creams, and others. As of 25 May 2026, Bharat Parenterals Limited share price is ₹1,374.35. The stock opened at ₹1,308.00, compared to its previous close of ₹1,383.95. During today's trading session, Bharat Parenterals Limited share price moved in the range of ₹1,308.00 to ₹1,394.80, with an average price of ₹1,351.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,308.00 and a high of ₹1,394.80.
The market capitalization of Bharat Parenterals Limited is ₹954 Crs, with a P/E ratio of -34.9 and a dividend yield of 0.07%.